Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
Article (February 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article (February 2024)
Article in Experimental Hematology & Oncology (September 2023)
Article in Highlights in Science Engineering and Technology (July 2023)